HGH, GRENAA A/S: Financial statements 2020
CVR: 33120753
Source: annual report 2020, Danish Business Authority
01/10/2019 – 30/09/2020
HGH, GRENAA A/S (CVR 33120753) has filed annual accounts for 2020. In 2020, the company reported a net result of DKK -346,273 compared with DKK -251,838 the year before. Equity in the 2020 report amounted to DKK 798,993. The solvency ratio was 55.5%.
- Profit/Loss
- DKK -346,273
- Equity
- DKK 798,993
- Total Assets
- DKK 1,440,131
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | - | -346 t. | 799 t. | 0 |
| 2019 | - | - | -252 t. | 1.1 mio. | - |
| 2018 | - | - | -72 t. | 1.4 mio. | - |
| 2017 | - | - | -306 t. | 1.5 mio. | - |
| 2016 | - | - | -446 t. | 1.8 mio. | - |
Official annual report
How creditworthy is HGH, GRENAA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
HGH, GRENAA A/S has published its annual report for 2019. The net result was DKK -251,838.
About HGH, GRENAA A/S
HGH, GRENAA A/S is a Danish company of the type Aktieselskab based in Grenaa, founded in 2010. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Louise Rørbæk Jensen. The board consists of Mette Rørbæk Jensen (chair), Jess Stegger and Louise Rørbæk Jensen. The company is owned by Boet efter Ulla Merethe Rørbæk Jensen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,125 and a net result of DKK -1,506,927 compared with DKK 84,836 the year before. Equity in the 2025 report amounted to DKK -789,690.